nifedipine has been researched along with Bladder Diseases in 6 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Excerpt | Relevance | Reference |
---|---|---|
"As hypertension (HT) is one of the risk factors for lower urinary tract symptoms, we investigated the effect of an angiotensin II type I receptor blocker, olmesartan, on bladder dysfunction in the spontaneously hypertensive rat (SHR)." | 3.80 | Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress. ( Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P, 2014) |
"Bladder function of db/db (type 2 diabetes) and wild type (Wt) mice was evaluated by behavioral tests and in vivo cystometry." | 1.40 | T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction. ( Chitaley, K; Jiang, X; Luttrell, I; Yang, CC, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, X | 1 |
Luttrell, I | 1 |
Chitaley, K | 1 |
Yang, CC | 1 |
Shimizu, S | 1 |
Saito, M | 1 |
Oiwa, H | 1 |
Ohmasa, F | 1 |
Tsounapi, P | 1 |
Oikawa, R | 1 |
Dimitriadis, F | 1 |
Martin, DT | 1 |
Satoh, I | 1 |
Kinoshita, Y | 1 |
Tomita, S | 1 |
Yono, M | 1 |
Yoshida, M | 1 |
Yamamoto, Y | 1 |
Imanishi, A | 1 |
Fukagawa, A | 1 |
Latifpour, J | 1 |
Eto, M | 1 |
Leiria, LO | 1 |
Mónica, FZ | 1 |
Carvalho, FD | 1 |
Claudino, MA | 1 |
Franco-Penteado, CF | 1 |
Schenka, A | 1 |
Grant, AD | 1 |
De Nucci, G | 1 |
Antunes, E | 1 |
Levin, RM | 1 |
Kitada, S | 1 |
Hayes, L | 1 |
Kau, ST | 1 |
Fromm-Freeck, S | 1 |
Howe, BB | 1 |
Wein, AJ | 1 |
Kontani, H | 1 |
Nakagawa, M | 1 |
Takeno, S | 1 |
Sakai, T | 1 |
6 other studies available for nifedipine and Bladder Diseases
Article | Year |
---|---|
T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type | 2014 |
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Bl | 2014 |
Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Doxazosin; Gene Expression; Gene Expression | 2010 |
Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels.
Topics: Amides; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chloride; Carbachol; Ch | 2011 |
Experimental hyperreflexia: effect of intravesical administration of various agents.
Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Diltiazem; Electric Stimulation; Electromyography; | 1991 |
Evaluation of drugs for treatment of urinary bladder dysfunction in conscious rats with intact pelvic nerve and after resection of the left pelvic nerve.
Topics: Animals; Atropine; Butylamines; Decerebrate State; Drug Evaluation; Male; Mandelic Acids; Nifedipine | 1990 |